ADVANCED ENDOMETRIAL CANCER

Clinical trials for ADVANCED ENDOMETRIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new ADVANCED ENDOMETRIAL CANCER trials appear

Sign up with your email to follow new studies for ADVANCED ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Terminated 1

New combo therapy tested for Tough-to-Treat uterine cancer

Disease control Recruiting now

This study is testing two treatment approaches for advanced endometrial (uterine) cancer that has returned or spread after standard chemotherapy. It will compare an immunotherapy drug (envafolimab) given alone to the same drug combined with a targeted therapy (lenvatinib). The ma…

Matched conditions: ADVANCED ENDOMETRIAL CANCER

Phase: PHASE2 • Sponsor: 3D Medicines (Sichuan) Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

ADVANCED ENDOMETRIAL CANCER

Get alerted when new ADVANCED ENDOMETRIAL CANCER trials appear

New combo therapy tested for Tough-to-Treat uterine cancer